Loading...
XCNQ
INNO
Market cap7mUSD
Aug 28, Last price  
2.17CAD
Name

Innocan Pharma Corp

Chart & performance

D1W1MN
XCNQ:INNO chart
P/E
P/S
0.26
EPS
Div yield, %
Shrs. gr., 5y
-48.91%
Rev. gr., 5y
406.29%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
IPO date
Sep 24, 2019
Employees
Domiciled in
IL
Incorporated in
CA

Valuation

No data to show